financetom
Business
financetom
/
Business
/
Vizsla Silver Highlights Several Multi-Kilo Silver, Gold Intercepts Along Napoleon Vein System
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Vizsla Silver Highlights Several Multi-Kilo Silver, Gold Intercepts Along Napoleon Vein System
May 22, 2024 5:31 AM

08:03 AM EDT, 05/22/2024 (MT Newswires) -- Vizsla Silver ( VZLA ) , which saw its shares gain 6.2% on the TSX yesterday, on Wednesday highlighted results from 16 new drill holes targeting the Napoleon Vein at its flagship Panuco silver-gold project in Mexico.

The new drill results are centered on the western portion of the district and are part of Vizsla's more than 30,000-meter resource conversion and expansion drill program.

Among the highlights, NP-24-431 returned 2,561 grams per tonne of silver equivalent over 2.40 meters true width, including 4,121 grams per tonne of silver equivalent over 1.24 meters true width.

NAP-2023-004 returned 696 grams per tonne of silver equivalent over 6.50 meters true width, including 1,038 grams per tonne of silver equivalent over 3.65 meters true width.

Additionally, NP-24-429 returned 4,533 grams per tonne of silver equivalent over 1.30 meters true width; and 4,525 grams per tonne of silver equivalent over 0.80 meters true width.

NP-24-435 returned 2,156 grams per tonne of silver equivalent over 1.40 meters true width.

The company's shares, which gained 1.7% in premarket US trading on Wednesday, rose more than 6% in Canada on Tuesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Intercontinental Exchange launches private credit platform to address transparency concerns
Intercontinental Exchange launches private credit platform to address transparency concerns
Mar 17, 2026
March 17 (Reuters) - New York Stock Exchange-parent Intercontinental Exchange ( ICE ) said on Tuesday it has launched a product to bring greater transparency to the private credit market, an asset class beleaguered by heightened investor concerns. Sentiment toward the private credit market has weakened amid worries about valuations and transparency, amplified by last year's bankruptcies of auto-parts supplier...
Cencora's CFO Cleary to retire
Cencora's CFO Cleary to retire
Mar 17, 2026
March 17 (Reuters) - Drug distributor Cencora ( COR ) said on Tuesday that Chief Financial Officer James Cleary will retire on June 30, adding that it was considering internal and external candidates to succeed him. * Cleary will assist in the search process and serve as an adviser through the end of 2026 to ensure a smooth transition, the...
Wipro, Harness Collaborate to Support Global Enterprises' AI-Native Software Delivery
Wipro, Harness Collaborate to Support Global Enterprises' AI-Native Software Delivery
Mar 17, 2026
09:19 AM EDT, 03/17/2026 (MT Newswires) -- Wipro ( WIT ) and artificial intelligence software delivery platform Harness said Tuesday that they have collaborated to support global companies' AI-native software delivery. Financial terms weren't disclosed. The partnership will integrate Wipro's ( WIT ) agent-native delivery platform Wega with Harness' AI software delivery platform, according to the parties. The companies said...
Aldeyra Therapeutics Shares Fall Pre-Bell After US FDA Response Cites Lack of Efficacy Data for Dry Eye Drug
Aldeyra Therapeutics Shares Fall Pre-Bell After US FDA Response Cites Lack of Efficacy Data for Dry Eye Drug
Mar 17, 2026
09:17 AM EDT, 03/17/2026 (MT Newswires) -- Aldeyra Therapeutics ( ALDX ) shares were down more than 73% in recent Tuesday premarket activity after the biotechnology company said it has received a complete response letter from the US Food and Drug Administration for its reproxalap application for dry eye disease, citing insufficient evidence of effectiveness. The drugmaker said the FDA...
Copyright 2023-2026 - www.financetom.com All Rights Reserved